Literature DB >> 20442726

Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.

Kati Alakurtti1, Sargo Aalto, Jarkko J Johansson, Kjell Någren, Terhi Tuokkola, Vesa Oikonen, Matti Laine, Juha O Rinne.   

Abstract

Positron emission tomography (PET) imaging of small striatal brain structures such as the ventral striatum (VST) has been hampered by low spatial resolution causing partial-volume effects. The high-resolution research tomograph (HRRT) is a brain-dedicated PET scanner that has considerably better spatial resolution than its predecessors. However, its superior spatial resolution is associated with a lower signal-to-noise ratio. We evaluated the test-retest reliability of the striatal and thalamic dopamine D(2) receptor binding using the HRRT scanner. Seven healthy male volunteers underwent two [(11)C]raclopride PET scans with a 2.5-hour interval. Dopamine D(2) receptor availability was quantified as binding potential (BP(ND)) using the simplified reference tissue model. To evaluate the reproducibility of repeated BP(ND) estimations, absolute variability (VAR) and intraclass correlation coefficients (ICCs) were calculated. VAR values indicated fairly good reproducibility and were 3.6% to 4.5% for the caudate nucleus and putamen and 4.5% to 6.4% for the lateral and medial part of the thalamus. In the VST, the VAR value was 5.8% when the definition was made in the coronal plane. However, the ICC values were only moderate, in the range of 0.34 to 0.66, for all regions except the putamen (0.87). Experimental signal processing methods improved neither ICC nor VAR values significantly.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20442726      PMCID: PMC3049480          DOI: 10.1038/jcbfm.2010.64

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  26 in total

Review 1.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

2.  Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.

Authors:  Andrea Varrone; Nils Sjöholm; Lars Eriksson; Balazs Gulyás; Christer Halldin; Lars Farde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-13       Impact factor: 9.236

3.  Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.

Authors:  H Hall; G Sedvall; O Magnusson; J Kopp; C Halldin; L Farde
Journal:  Neuropsychopharmacology       Date:  1994-12       Impact factor: 7.853

Review 4.  Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease.

Authors:  Valtteri Kaasinen; Juha O Rinne
Journal:  Neurosci Biobehav Rev       Date:  2002-11       Impact factor: 8.989

5.  Age-related cognitive deficits mediated by changes in the striatal dopamine system.

Authors:  L Bäckman; N Ginovart; R A Dixon; T B Wahlin; A Wahlin; C Halldin; L Farde
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

6.  Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.

Authors:  R M Kessler; W O Whetsell; M S Ansari; J R Votaw; T de Paulis; J A Clanton; D E Schmidt; N S Mason; R G Manning
Journal:  Brain Res       Date:  1993-04-23       Impact factor: 3.252

Review 7.  Basal ganglia outputs and motor control.

Authors:  E V Evarts; S P Wise
Journal:  Ciba Found Symp       Date:  1984

8.  Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.

Authors:  O Mawlawi; D Martinez; M Slifstein; A Broft; R Chatterjee; D R Hwang; Y Huang; N Simpson; K Ngo; R Van Heertum; M Laruelle
Journal:  J Cereb Blood Flow Metab       Date:  2001-09       Impact factor: 6.200

Review 9.  The neurophysiologic basis of abnormal movements in basal ganglia disorders.

Authors:  M R DeLong
Journal:  Neurobehav Toxicol Teratol       Date:  1983 Nov-Dec

10.  Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.

Authors:  J Hirvonen; S Aalto; V Lumme; K Någren; J Kajander; H Vilkman; N Hagelberg; V Oikonen; J Hietala
Journal:  Nucl Med Commun       Date:  2003-12       Impact factor: 1.690

View more
  14 in total

1.  Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain.

Authors:  Jussi Lehto; Jere R Virta; Vesa Oikonen; Anne Roivainen; Pauliina Luoto; Eveliina Arponen; Semi Helin; Johanna Hietamäki; Aila Holopainen; Marita Kailajärvi; Juha M Peltonen; Juha Rouru; Jukka Sallinen; Kirsi Virtanen; Iina Volanen; Mika Scheinin; Juha O Rinne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-09       Impact factor: 9.236

2.  Comparison of HRRT and HR+ scanners for quantitative (R)-[11C]verapamil, [11C]raclopride and [11C]flumazenil brain studies.

Authors:  Floris H P van Velden; Syahir M Mansor; Daniëlle M E van Assema; Bart N M van Berckel; Femke E Froklage; Shaonan Wang; Robert C Schuit; Marie-Claude Asselin; Adriaan A Lammertsma; Ronald Boellaard; Marc C Huisman
Journal:  Mol Imaging Biol       Date:  2015-02       Impact factor: 3.488

Review 3.  Selectivity of probes for PET imaging of dopamine D3 receptors.

Authors:  Robert K Doot; Jacob G Dubroff; Kyle J Labban; Robert H Mach
Journal:  Neurosci Lett       Date:  2018-03-05       Impact factor: 3.046

4.  Long-term test-retest reliability of striatal and extrastriatal dopamine D2/3 receptor binding: study with [(11)C]raclopride and high-resolution PET.

Authors:  Kati Alakurtti; Jarkko J Johansson; Juho Joutsa; Matti Laine; Lars Bäckman; Lars Nyberg; Juha O Rinne
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-08       Impact factor: 6.200

5.  High long-term test-retest reliability for extrastriatal 11C-raclopride binding in healthy older adults.

Authors:  Nina Karalija; Lars Jonassson; Jarkko Johansson; Goran Papenberg; Alireza Salami; Micael Andersson; Katrine Riklund; Lars Nyberg; Carl-Johan Boraxbekk
Journal:  J Cereb Blood Flow Metab       Date:  2019-09-10       Impact factor: 6.200

6.  Test-retest reliability of [11C]AZ10419369 binding to 5-HT(1B) receptors in human brain.

Authors:  Magdalena Nord; Sjoerd J Finnema; Martin Schain; Christer Halldin; Lars Farde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-05       Impact factor: 9.236

7.  Failure to detect amphetamine-induced dopamine release in the cortex with [11 C]FLB 457 positron emission tomography (PET): Methodological considerations.

Authors:  Joshua Gertler; Savannah Tollefson; Rehima Jordan; Michael L Himes; N Scott Mason; W Gordon Frankle; Rajesh Narendran
Journal:  Synapse       Date:  2018-07-13       Impact factor: 2.562

8.  Intravenous ethanol increases dopamine release in the ventral striatum in humans: PET study using bolus-plus-infusion administration of [(11)C]raclopride.

Authors:  Sargo Aalto; Kimmo Ingman; Kati Alakurtti; Valtteri Kaasinen; Jussi Virkkala; Kjell Någren; Juha O Rinne; Harry Scheinin
Journal:  J Cereb Blood Flow Metab       Date:  2014-12-10       Impact factor: 6.200

9.  Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.

Authors:  Eero Rissanen; Jere R Virta; Teemu Paavilainen; Jouni Tuisku; Semi Helin; Pauliina Luoto; Riitta Parkkola; Juha O Rinne; Laura Airas
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-22       Impact factor: 6.200

10.  Parametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET Scanner.

Authors:  Jean-Dominique Gallezot; Ming-Qiang Zheng; Keunpoong Lim; Shu-fei Lin; David Labaree; David Matuskey; Yiyun Huang; Yu-Shin Ding; Richard E Carson; Robert T Malison
Journal:  J Nucl Med       Date:  2014-04-14       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.